Iraj HOSSEINI

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies
- Patent number 11,466,094
- Issue date Oct 11, 2022
- Genentech, Inc.
- Yu-Waye Chu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
- Publication number 20240376223
- Publication date Nov 14, 2024
- Genentech, Inc.
- Yu-Waye CHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUANTITATIVE SYSTEMS PHARMACOLOGY IN CYTOKINE-BASED CANCER IMMUNOTH...
- Publication number 20240331829
- Publication date Oct 3, 2024
- Genentech, Inc.
- Mohammad Jafarnejad
Information Patent Application
DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
- Publication number 20240132613
- Publication date Apr 25, 2024
- Genentech, Inc.
- Yu-Waye CHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
- Publication number 20230242659
- Publication date Aug 3, 2023
- Genentech, Inc.
- Yu-Waye CHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C-C MOTIF CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES AND METHODS O...
- Publication number 20230049152
- Publication date Feb 16, 2023
- Genentech, Inc.
- Gautham Gampa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBCUTANEOUS DOSING OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
- Publication number 20220153858
- Publication date May 19, 2022
- Genentech, Inc.
- Chi-Chung LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
- Publication number 20180134798
- Publication date May 17, 2018
- Genentech, Inc.
- Yu-Waye CHU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Iraj HOSSEINI

Person

Patents Grantslast 30 patents

Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies

Patents Applicationslast 30 patents

DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

QUANTITATIVE SYSTEMS PHARMACOLOGY IN CYTOKINE-BASED CANCER IMMUNOTH...

DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

ANTI-C-C MOTIF CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES AND METHODS O...

SUBCUTANEOUS DOSING OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES

DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES